Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy

Background The current study aimed to evaluate the serum pretreatment lactate dehydrogenase (LDH) and overall survival (OS) in small cell lung cancer (SCLC) patients who received first‐line platinum‐containing chemotherapy. Methods A total of 234 SCLC patients, who received first‐line platinum‐based...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Man He, Xiaorui Chi, Xinyan Shi, Yang Sun, Xue Yang, Leirong Wang, Bingrui Wang, Hongmei Li
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
LDH
OS
Acceso en línea:https://doaj.org/article/47ae4f268c6a44c288667897141c8b59
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!